Omega Healthcare Investors Inc. - OHI STOCK NEWS

Omega Healthcare Investors (NYSE:OHI) announced significant leadership changes as part of its long-term succession planning. Matthew Gourmand, formerly Senior VP of Corporate Strategy & Investor Relations, has been appointed as President, while Vikas Gupta, previously Senior VP of Acquisitions & Development, has been named Chief Investment Officer.

After 23 years of service, Dan Booth has stepped down from his position as Chief Operating Officer but will continue in a consulting role for 12 months. CEO Taylor Pickett expressed confidence in the new appointments, citing their industry experience, business acumen, and work ethic as key factors for driving the company's next growth phase.

Omega is a REIT specializing in long-term healthcare facilities, primarily skilled nursing and assisted living facilities, with assets across the US and UK operated under triple-net lease structures.

Omega Healthcare Investors (NYSE: OHI) reported strong Q3 2024 results with net income of $115 million ($0.42 per share), up from $94 million in Q3 2023. The company completed $834 million in new investments year-to-date, including $440 million in Q3. Revenue increased by $34 million to $276 million compared to Q3 2023. The company raised its 2024 AFFO guidance to $2.84-$2.86 per share from previous $2.78-$2.84. Notable Q3 activities include issuing 14 million common shares for $530 million and acquiring the remaining 51% stake in Cindat JV for $100.9 million plus assumed mortgage.

Omega Healthcare Investors (NYSE:OHI) has declared a quarterly cash dividend of $0.67 per share on its common stock. The dividend will be paid on November 15, 2024, to stockholders of record as of November 4, 2024. Omega is a real estate investment trust specializing in healthcare facilities, primarily skilled nursing and assisted living facilities, with properties across the US and UK operated under triple-net lease structures.

Inspīr Carnegie Hill, Maplewood Senior Living's luxury senior living property in New York City, has won the 2024 Senior Living Development Award from The Americas Property Awards. This prestigious accolade recognizes Inspīr's innovation in senior living design, wellness offerings, and personalized care.

The property distinguishes itself through exquisite design fostering a connection to nature, state-of-the-art technology enhancing resident care, and access to Manhattan's world-class amenities. Inspīr is expanding with a second location in Washington D.C., set to open in January 2025.

Inspīr offers assisted living, memory care, and enhanced care options in customized private apartments. The brand is developed by Maplewood Senior Living in partnership with Omega Healthcare Investors, Inc. (NYSE: OHI).

Omega Healthcare Investors (NYSE:OHI) has announced its schedule for releasing third quarter 2024 earnings results. The company will release its earnings for the quarter ended September 30, 2024, on Wednesday, October 30, 2024, after market close. Following this, Omega will conduct a conference call on Thursday, October 31, 2024, at 10 a.m. Eastern Time to review the Q3 2024 results and current developments.

Investors can access the conference call via webcast on Omega's website or by phone. The US dial-in number is (800) 715-9871, while the international toll-free number is +1 (646) 307-1963. The conference ID is 1388157. Participants are advised to dial in 15 minutes before the call starts. Webcast replays will be available on the website for about two weeks after the call.

Omega Healthcare Investors (NYSE: OHI) reported Q2 2024 results with net income of $117 million ($0.45 per share), up from $62 million in Q2 2023. Nareit FFO increased to $189 million ($0.72 per share) from $155 million. The company completed $221 million in new investments during Q2, including $115 million in real estate acquisitions and $106 million in real estate loans. Year-to-date, Omega has invested $648 million in new investments. Due to strong performance, Omega increased its 2024 AFFO guidance to $2.78-$2.84 per share from the previous $2.70-$2.80. The company also reported improvements in tenant operating metrics and portfolio coverage.

Omega Healthcare Investors (NYSE:OHI) has announced its quarterly dividend and second quarter earnings release schedule. The company's Board of Directors declared a cash dividend of $0.67 per share on its common stock, payable on August 15, 2024, to stockholders of record as of August 5, 2024. Omega will release its Q2 2024 earnings results on August 1, 2024, after market close, followed by a conference call on August 2, 2024, at 10 a.m. Eastern Time. Investors can access the webcast through Omega's website, and replays will be available for approximately two weeks. Omega is a real estate investment trust focusing on long-term healthcare industry investments, primarily in skilled nursing and assisted living facilities across the US and UK.

Omega Healthcare Investors (NYSE: OHI) issued a statement regarding LaVie Care Centers' Chapter 11 bankruptcy filing in Georgia. Omega believes this step is important for LaVie to achieve operational solvency and enhanced liquidity. To support LaVie during the bankruptcy, Omega will provide $10 million for debtor-in-possession financing. Omega's focus remains on maintaining quality care and supporting employees and key vendors. The company aims to sustain LaVie's current cash flow, which supports $36 million in annualized rent. Omega's loan commitment requires LaVie to pay $3 million in monthly rent for 30 properties, subject to court approval.

Omega Healthcare Investors, Inc. (NYSE: OHI) reported strong first quarter 2024 results with net income of $69 million and various financial metrics showing growth compared to Q1 2023. The company completed $240 million in new investments and repaid a $400 million debt maturity. CEO Taylor Pickett highlighted the positive financial performance and solid balance sheet positioning for future capital allocation efforts. However, the company expressed disappointment with the final ruling around minimum staffing, believing it will burden the industry. Omega also affirmed its 2024 Adjusted FFO guidance between $2.70 and $2.80 per diluted share.